Conditions: Glaucoma
Keywords: Open-angle glaucoma Ocular hypertension Pigment dispersion glaucoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 74
Healthy volunteers: no

Brief summary:
The purpose of this study was to assess the safety and efficacy of switching to Azarga from prior pharmacotherapy in patients with open-angle glaucoma.

Detailed description:

Arms:
arm 1: Brinzolamide 1% and timolol 0.5% fixed combination eye drops, one drop administered to the study eye(s) twice daily (8:00 am and 8:00 pm) for up to 8 weeks.

Interventions: intervention 1: Brinzolamide 1% and timolol 0.5% fixed combination eye drops
Intervention descriptions: intervention 1: None

Protocol document: